elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q42012709-2CFBCB08-49E0-48DF-8605-30EC8C9453FA
Q42012709-2CFBCB08-49E0-48DF-8605-30EC8C9453FA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42012709-2CFBCB08-49E0-48DF-8605-30EC8C9453FA
D-optimal Design for Preparation and Optimization of Fast Dissolving Bosentan Nanosuspension.
P2860
Q42012709-2CFBCB08-49E0-48DF-8605-30EC8C9453FA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42012709-2CFBCB08-49E0-48DF-8605-30EC8C9453FA
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b5830a6ae6d9712436f4f92d21ca3ea4cde62baf
P2860
Bosentan improves exercise capacity in adolescents and adults after Fontan operation: the TEMPO (Treatment With Endothelin Receptor Antagonist in Fontan Patients, a Randomized, Placebo-Controlled, Double-Blind Study Measuring Peak Oxygen Consumption